
Ali focuses
Articles
-
May 2, 2024 |
ark-invest.com | Ali focuses |Frank Downing |Alexandra Urman
On this episode of FYI, Director of Next Generation Internet Research Frank Downing and Analyst Ali Urman interview Dr. Issam El Naqa, the founding chair of the Department of Machine Learning at the Moffitt Cancer Center. Dr. El Naqa shares his journey from electrical engineering to spearheading innovative uses of artificial intelligence (AI) in medical physics and oncology.
-
Mar 18, 2024 |
ark-invest.com | Ali focuses |Sam Korus |Jozef Soja |Lorenzo Valente
In 2021, CAR-T cell therapy gained acclaim after scientists demonstrated complete remission rates in the 62% to 95% range when used to target CD19 in patients whose acute lymphoblastic leukemia had relapsed.vii Last year, ARK highlighted the story of Alyssa, a 13-year-old girl in the UK who had been diagnosed with T-Cell Acute Lymphoblastic Leukemia, a type of cancer that affects the immune system. CAR-T cell therapy treatment wiped out Alyssa’s cancer.
-
Mar 18, 2024 |
ark-invest.com | Ali focuses |Lorenzo Valente |Sam Korus |Jozef Soja
In 2021, CAR-T cell therapy gained acclaim after scientists demonstrated complete remission rates in the 62% to 95% range when used to target CD19 in patients whose acute lymphoblastic leukemia had relapsed.vii Last year, ARK highlighted the story of Alyssa, a 13-year-old girl in the UK who had been diagnosed with T-Cell Acute Lymphoblastic Leukemia, a type of cancer that affects the immune system. CAR-T cell therapy treatment wiped out Alyssa’s cancer.
-
Feb 29, 2024 |
ark-invest.com | Ali focuses |Alexandra Urman
In this episode of For Your Innovation, Ali Urman chats with Ben Lamm, CEO of Colossal, about the groundbreaking venture aimed at resurrecting extinct species, starting with the woolly mammoth. Lamm shares insights into his journey from tech to biotech, highlighting the fusion of artificial intelligence (AI), automation, and genetic editing to challenge the boundaries of science and conservation.
-
Feb 14, 2024 |
ark-invest.com | Ali focuses |Nicholas Grous |Sam Korus |Alexandra Urman
$7 trillion for an AI chip? This week, Autonomous Technology and Robotics Director of Research Sam Korus and Associate Portfolio Manager Nick Grous are joined by Chief Futurist Brett Winton and Multi-Omics Analyst Ali Urman. Together they discuss Sam Altman's plan to raise $7 trillion for an AI chip, and drug pricing.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →